Latanoprost Favored Over Brimonidine For Lowering Intra-Ocular Pressure

Reuters Health

A meta-analysis of 14 clinical trials evaluating the efficacy of latanoprost and brimonidine in lowering intra-ocular pressure (IOP) shows that the prostaglandin E2 analogue is more effective than the alpha-2-adrenergic agonist.
  • <<
  • >>

Comments